Auditory evoked potentials remain abnormal after CPAP treatment in patients with severe obstructive sleep apnoea

被引:15
|
作者
Vakulin, Andrew [1 ,2 ]
Catcheside, Peter G. [1 ,2 ,5 ]
Baulk, Stuart D. [3 ]
Antic, Nick A. [1 ,5 ]
van den Heuvel, Cameron J. [6 ]
Banks, Siobhan [4 ]
McEvoy, R. Doug [1 ,2 ,5 ]
机构
[1] Repatriat Gen Hosp, Adelaide Inst Sleep Hlth, Adelaide, SA 5041, Australia
[2] Univ Adelaide, Sch Med Sci, Discipline Physiol, Adelaide, SA 5005, Australia
[3] Integrated Safety Support, Adelaide, SA 5071, Australia
[4] Univ S Australia, Ctr Sleep Res, Adelaide, SA 5000, Australia
[5] Flinders Univ S Australia, Dept Med, Bedford Pk, SA 5041, Australia
[6] Univ Adelaide, Womens & Childrens Hosp, Childrens Res Ctr, Adelaide, SA 5006, Australia
基金
英国医学研究理事会;
关键词
Obstructive sleep apnoea; ERP; CPAP; EVENT-RELATED POTENTIALS; SIMULATED DRIVING PERFORMANCE; POSITIVE AIRWAY PRESSURE; DAYTIME SLEEPINESS; BREATHING DISORDERS; BRAIN-DYSFUNCTION; P300; LATENCIES; DEPRIVATION; ADULTS; WAKEFULNESS;
D O I
10.1016/j.clinph.2011.07.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To assess the effects of 3 months of optimal CPAP treatment on auditory event related potentials (AERP) in patients with severe obstructive sleep apnoea (OSA) compared with healthy controls. Methods: Auditory odd-ball related N1, P2, N2 and P3 AERP components were assessed in 9 severe OSA subjects and 9 healthy controls at baseline evaluation and at similar to 3 months follow-up in both groups, with OSA subjects treated with continuous positive air-way pressure (CPAP) during this period. Results: Severe OSA subjects showed significantly delayed, P2, N2 and P3 latencies, and significantly different P2 and P3 amplitudes compared to controls at baseline (group effect, all p < 0.05). At follow-up evaluation P3 latency shortened in treated OSA patients but remained prolonged compared to controls (group by treatment interaction, p < 0.05) despite high CPAP compliance (6 h/night). The earlier AERP (P2 and N2) components did not change in either controls or OSA patients at follow-up and remained different in patients versus controls. Conclusions: This study demonstrates that in severe OSA patients AERP responses show minimal or no improvement and remain abnormal following 3 months of optimal CPAP treatment. Significance: Persistent cortical sensory processing abnormalities despite treatment in severe OSA may have implications for daytime neurobehavioral performance and safety in OSA patients. AERP responses may help identify residual performance deficits and risks. (C) 2011 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:310 / 317
页数:8
相关论文
共 50 条
  • [21] Effects of continuous positive airway pressure treatment on cognitive functions in patients with severe obstructive sleep apnoea
    Jurado-Gamez, B.
    Guglielmi, O.
    Gude, F.
    Buela-Casal, G.
    NEUROLOGIA, 2016, 31 (05): : 311 - 318
  • [22] Evaluation of an auto-CPAP device for treatment of obstructive sleep apnoea
    Ficker, JH
    Wiest, GH
    Lehnert, G
    Wiest, B
    Hahn, EG
    THORAX, 1998, 53 (08) : 643 - 648
  • [23] Effects of CPAP on energy expenditure in obese obstructive sleep apnoea patients: A pilot study
    Shechter, Ari
    Pham, Tiffany
    Rising, Russell
    St-Onge, Marie-Pierre
    OBESITY RESEARCH & CLINICAL PRACTICE, 2015, 9 (06) : 618 - 621
  • [24] Ventilatory and cerebrovascular responses to hypercapnia in patients with obstructive sleep apnoea: Effect of CPAP therapy
    Foster, Glen E.
    Hanly, Patrick J.
    Ostrowski, Michele
    Poulin, Marc J.
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2009, 165 (01) : 73 - 81
  • [25] Two months follow up of auto-CPAP treatment in patients with obstructive sleep apnoea
    Boudewyns, A
    Grillier-Lanoir, V
    Willemen, MJ
    De Cock, WA
    Van de Heyning, PH
    De Backer, WA
    THORAX, 1999, 54 (02) : 147 - 149
  • [26] CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD
    Machado, M-C. L.
    Vollmer, W. M.
    Togeiro, S. M.
    Bilderback, A. L.
    Oliveira, M-V. C.
    Leitao, F. S.
    Queiroga, F., Jr.
    Lorenzi-Filho, G.
    Krishinan, J. A.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (01) : 132 - 137
  • [27] Bed partners' and patients' experiences after treatment of obstructive sleep apnoea with an oral appliance
    Tegelberg, Ake
    Nohlert, Eva
    Bergman, Lars-Eric
    Andren, Ann
    SWEDISH DENTAL JOURNAL, 2012, 36 (01) : 35 - 43
  • [28] Cognitive function and depressivity before and after CPAP treatment in obstructive sleep apnea patients
    Hobzova, Milada
    Hubackova, Lia
    Vanek, Jakub
    Genzor, Samuel
    Ociskova, Marie
    Grambal, Ales
    Prasko, Jan
    NEUROENDOCRINOLOGY LETTERS, 2017, 38 (03) : 145 - 153
  • [29] Treatment of obstructive sleep apnoea using nasal CPAP in children with craniofacial dysostoses
    Gonsalez, S
    Thompson, D
    Hayward, R
    Lane, R
    CHILDS NERVOUS SYSTEM, 1996, 12 (11) : 713 - 719
  • [30] Narrative review of contemporary treatment options in the care of patients with obstructive sleep apnoea
    Ferguson, Mark S.
    Magill, Jennifer Claire
    Kotecha, Bhik T.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2017, 11 (11) : 411 - 423